
Wednesday, November 25, 2020 2:54:24 PM
Of the six patients receiving a certain dose, and after lymphodepletion, three demonstrated regression of soft tissue and bone marrow disease.

Liked By
Spread the love. Be the first to like this post!
Recent AUTL News
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 03/20/2023 01:14:19 PM
- Autolus Therapeutics announces resignation of Chief Financial Officer • GlobeNewswire Inc. • 03/14/2023 11:00:00 AM
- Autolus Therapeutics Has No Business Relationship with Silicon Valley Bank • GlobeNewswire Inc. • 03/13/2023 11:00:00 AM
- Autolus Therapeutics Reports Full Year 2022 Financial Results and Operational Progress • GlobeNewswire Inc. • 03/07/2023 12:00:00 PM
- Autolus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 7, 2023 • GlobeNewswire Inc. • 02/15/2023 12:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 10:24:32 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 05:10:40 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 03:29:38 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/23/2023 10:08:34 PM
- Autolus Therapeutics announces Board changes • GlobeNewswire Inc. • 01/20/2023 12:00:00 PM
- Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease • GlobeNewswire Inc. • 01/09/2023 12:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/21/2022 10:21:21 PM
- Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs • GlobeNewswire Inc. • 12/21/2022 09:01:00 PM
- Mizuho Securities Remains a Buy on Autolus Therapeutics (AUTL) • TipRanks • 12/12/2022 08:25:12 PM
- Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022 • GlobeNewswire Inc. • 12/12/2022 03:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/12/2022 11:01:18 AM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 12/12/2022 11:01:09 AM
- Needham Remains a Buy on Autolus Therapeutics (AUTL) • TipRanks • 12/09/2022 02:15:16 PM
- Autolus Tanks After Pricing of Public Offering • TipRanks • 12/09/2022 10:58:04 AM
- Autolus Announces Pricing of Public Offering • GlobeNewswire Inc. • 12/09/2022 02:11:25 AM
- Mizuho Securities Keeps Their Buy Rating on Autolus Therapeutics (AUTL) • TipRanks • 12/08/2022 11:45:09 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/08/2022 09:17:44 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 12/08/2022 09:11:11 PM
- Autolus Announces Proposed Public Offering in the United States • GlobeNewswire Inc. • 12/08/2022 09:03:13 PM
- Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences • GlobeNewswire Inc. • 12/08/2022 09:02:48 PM
FEATURED Fineqia's EEA Unit Receives Approval of Base Prospectus for Issuing Exchange Traded Notes (ETNs) • Mar 28, 2023 9:37 AM
FEATURED Usha Resources Enters Hard-Rock Lithium Space with Acquisition of Significant Ontario Land Package with Highly Evolved LCT-Pegmatites • Mar 28, 2023 8:26 AM
FEATURED Edison Lithium Provides Update on Spin-Out of Cobalt Assets • Mar 28, 2023 8:09 AM
FEATURED Epazz Holdings: ZenaDrone, Inc. 1000 AI Predictive Received a Letter of Support from the US Airforce for Drone Cargo Delivery and Intent to Use ZenaDrone 1000 Platform • Mar 28, 2023 7:11 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM